<p>MTS assay performed to measure cell viability on Hmeso or H2373 MM cells in presence of Dox or cisplatin with and without specific caspase-1 inhibitor (A, B) or pan caspase inhibitor (C, D). The effect of these inhibitors on drug-induced caspase-1 activity was also performed in both MM cell lines (E, F). *p≤0.05 as compared to untreated controls (0); †p≤0.05 as compared to similar treatment without caspase- inhibitor, ‡ p≤0.05 as compared to low dose caspase inhibitor.</p
<p>Cells were pre-treated with 50 µM pan-caspase inhibitor Z-VAD-FMK prior to treatment with 3.2 µM ...
P-glycoprotein (P-gp) is a major factor in multidrug resistance (MDR) which is a serious obstacle in...
<p>Histological examination (Panel A) demonstrated cisplatin induced cleaved caspase 3 staining in k...
<p>Treatment of Hmeso MM cells with Dox or cisplatin resulted in increased NLRP3 protein levels (A) ...
Chemotherapy is a standard treatment modality in clinic that exerts an antitumor effect via the acti...
<p>Human MM cell lines were treated with different concentrations (0–100 μM) of cisplatin or Dox (0–...
a Images and cell viability of WT, Nlrp3-/-, Caspase-1-/- and Gsdmd-/- BMDMs left untreated or stimu...
<p>A) shows caspase 3/7 activity and B) cell lysis for U2OS cell line treated with increasing concen...
<p>Pan-caspase cleavage detection (ApoStat Apoptosis Detection Kit; R&D Systems) using flow cytometr...
<p>A549Pt and A549cisR cells were treated for 48 hours with 5 μM and 5 μM or 25 μM cisplatin (cisPt)...
This study measures the time-dependence of cellular caspase activation by anticancer drugs and compa...
<p>(A) Hmeso MM cells treated with either Dox or cisplatin caused increased release of HMGB1, FGF2, ...
P-glycoprotein (P-gp) is a major factor in multidrug resistance (MDR) which is a serious obstacle in...
<p>(<b>A</b>) MM cells were cultured with or without BMS for 24 hrs. MM cells were then collected an...
<p><b>A</b>. Caspase 3/7 activity of HT1080 and HCT116 cells treated with increasing concentrations ...
<p>Cells were pre-treated with 50 µM pan-caspase inhibitor Z-VAD-FMK prior to treatment with 3.2 µM ...
P-glycoprotein (P-gp) is a major factor in multidrug resistance (MDR) which is a serious obstacle in...
<p>Histological examination (Panel A) demonstrated cisplatin induced cleaved caspase 3 staining in k...
<p>Treatment of Hmeso MM cells with Dox or cisplatin resulted in increased NLRP3 protein levels (A) ...
Chemotherapy is a standard treatment modality in clinic that exerts an antitumor effect via the acti...
<p>Human MM cell lines were treated with different concentrations (0–100 μM) of cisplatin or Dox (0–...
a Images and cell viability of WT, Nlrp3-/-, Caspase-1-/- and Gsdmd-/- BMDMs left untreated or stimu...
<p>A) shows caspase 3/7 activity and B) cell lysis for U2OS cell line treated with increasing concen...
<p>Pan-caspase cleavage detection (ApoStat Apoptosis Detection Kit; R&D Systems) using flow cytometr...
<p>A549Pt and A549cisR cells were treated for 48 hours with 5 μM and 5 μM or 25 μM cisplatin (cisPt)...
This study measures the time-dependence of cellular caspase activation by anticancer drugs and compa...
<p>(A) Hmeso MM cells treated with either Dox or cisplatin caused increased release of HMGB1, FGF2, ...
P-glycoprotein (P-gp) is a major factor in multidrug resistance (MDR) which is a serious obstacle in...
<p>(<b>A</b>) MM cells were cultured with or without BMS for 24 hrs. MM cells were then collected an...
<p><b>A</b>. Caspase 3/7 activity of HT1080 and HCT116 cells treated with increasing concentrations ...
<p>Cells were pre-treated with 50 µM pan-caspase inhibitor Z-VAD-FMK prior to treatment with 3.2 µM ...
P-glycoprotein (P-gp) is a major factor in multidrug resistance (MDR) which is a serious obstacle in...
<p>Histological examination (Panel A) demonstrated cisplatin induced cleaved caspase 3 staining in k...